Jazz Pharmaceuticals
JAZZ
JAZZ
403 hedge funds and large institutions have $9.34B invested in Jazz Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 145 increasing their positions, 126 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.3% less ownership
Funds ownership: 93.38% → 92.07% (-1.3%)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
57% less call options, than puts
Call options by funds: $29.5M | Put options by funds: $68.1M
Holders
403
Holding in Top 10
9
Calls
$29.5M
Puts
$68.1M
Top Buyers
| 1 | +$38.5M | |
| 2 | +$35.3M | |
| 3 | +$35M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$32.3M |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$29.1M |
Top Sellers
| 1 | -$149M | |
| 2 | -$125M | |
| 3 | -$99.5M | |
| 4 |
Two Sigma Investments
New York
|
-$48.7M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$47.2M |